MetaCap

Axonex AI Group (AXNX) vs Callan JMB (CJMB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Axonex AI Group is the larger company by market cap ($5.3 million vs $3.2 million), about 1.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AXNX+16.92%CJMB-86.00%
+66%-14%-94%
Oct 13, 20261 yearNov 20, 2026
AXNX+76.17%CJMB-86.32%
+138%+20%-98%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AXNX versus CJMB key metrics
MetricAXNXCJMB
Share price$0.8301$0.301
Market cap$5.28M$3.21M
1-day change-8.28%-7.10%
YTD return—-72.88%
1-year return—-90.07%
EPS (TTM)$-10.37$-1.82
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$5.72M
Revenue growth (YoY)—-12.80%
Net income (latest FY)$-10.31M$-7.97M
Gross margin—36.77%
Operating margin—-122.91%
Net margin—-139.19%
52-week high$18.35$5.61
52-week low$0.68$0.26
Distance from 52-week high-95.48%-94.63%
Analyst consensushold—
Average volume2.01M4.73M
Shares outstanding6.08M10.66M
Employees79718
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Axonex AI Group

AXNX stock →

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI.

Consumer Discretionary · Business Services · 797 employees

About Callan JMB

CJMB stock →

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities.

Consumer Discretionary · Business Services · 18 employees

AXNX vs CJMB FAQ

Which is bigger, Axonex AI Group or Callan JMB?

Axonex AI Group (AXNX) is larger, with a market capitalization of $5.28M compared with $3.21M for Callan JMB (CJMB).

Are Axonex AI Group and Callan JMB in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons